| Product Code: ETC7220114 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
France saw a steady increase in granisetron import shipments in 2024, with top exporters being Germany, Ireland, China, USA, and India. The market displayed moderate concentration with a stable Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 was 2.25%, indicating consistent growth in demand. A notable growth rate of 7.79% from 2023 to 2024 suggests a positive momentum in the market, driven by diverse sources of supply from key exporting countries.
| 1 Executive Summary | 
| 2 Introduction | 
| 2.1 Key Highlights of the Report | 
| 2.2 Report Description | 
| 2.3 Market Scope & Segmentation | 
| 2.4 Research Methodology | 
| 2.5 Assumptions | 
| 3 France Granisetron Market Overview | 
| 3.1 France Country Macro Economic Indicators | 
| 3.2 France Granisetron Market Revenues & Volume, 2021 & 2031F | 
| 3.3 France Granisetron Market - Industry Life Cycle | 
| 3.4 France Granisetron Market - Porter's Five Forces | 
| 3.5 France Granisetron Market Revenues & Volume Share, By Product Type, 2021 & 2031F | 
| 3.6 France Granisetron Market Revenues & Volume Share, By Application, 2021 & 2031F | 
| 4 France Granisetron Market Dynamics | 
| 4.1 Impact Analysis | 
| 4.2 Market Drivers | 
| 4.2.1 Increasing prevalence of chemotherapy-induced nausea and vomiting (CINV) cases in France | 
| 4.2.2 Growing awareness and adoption of granisetron as an effective antiemetic drug | 
| 4.2.3 Favorable government regulations promoting the use of granisetron in cancer treatment | 
| 4.3 Market Restraints | 
| 4.3.1 Competition from alternative antiemetic drugs in the market | 
| 4.3.2 High cost associated with granisetron treatment | 
| 4.3.3 Side effects and safety concerns related to granisetron usage | 
| 5 France Granisetron Market Trends | 
| 6 France Granisetron Market, By Types | 
| 6.1 France Granisetron Market, By Product Type | 
| 6.1.1 Overview and Analysis | 
| 6.1.2 France Granisetron Market Revenues & Volume, By Product Type, 2021- 2031F | 
| 6.1.3 France Granisetron Market Revenues & Volume, By Transdermal, 2021- 2031F | 
| 6.1.4 France Granisetron Market Revenues & Volume, By Injection, 2021- 2031F | 
| 6.1.5 France Granisetron Market Revenues & Volume, By Oral, 2021- 2031F | 
| 6.2 France Granisetron Market, By Application | 
| 6.2.1 Overview and Analysis | 
| 6.2.2 France Granisetron Market Revenues & Volume, By Chemotherapy, 2021- 2031F | 
| 6.2.3 France Granisetron Market Revenues & Volume, By Post Operative, 2021- 2031F | 
| 7 France Granisetron Market Import-Export Trade Statistics | 
| 7.1 France Granisetron Market Export to Major Countries | 
| 7.2 France Granisetron Market Imports from Major Countries | 
| 8 France Granisetron Market Key Performance Indicators | 
| 8.1 Patient adherence rate to granisetron treatment | 
| 8.2 Number of healthcare facilities prescribing granisetron | 
| 8.3 Rate of new product developments and innovations in granisetron formulations | 
| 8.4 Patient satisfaction and reported outcomes with granisetron treatment | 
| 8.5 Level of reimbursement coverage for granisetron by healthcare payers in France | 
| 9 France Granisetron Market - Opportunity Assessment | 
| 9.1 France Granisetron Market Opportunity Assessment, By Product Type, 2021 & 2031F | 
| 9.2 France Granisetron Market Opportunity Assessment, By Application, 2021 & 2031F | 
| 10 France Granisetron Market - Competitive Landscape | 
| 10.1 France Granisetron Market Revenue Share, By Companies, 2024 | 
| 10.2 France Granisetron Market Competitive Benchmarking, By Operating and Technical Parameters | 
| 11 Company Profiles | 
| 12 Recommendations | 
| 13 Disclaimer |